Pyrazinamide
Pharmaceutical forms
Tablet
Country lists
ATC N/A
Composition 400 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.2.4. Antituberculosis medicines
  • No observations
PAHO Strategic Fund Medicine List
2.3. Antituberculosis med.
  • No observations
Tablet (dispersible)
Country lists
ATC N/A
Composition 150 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.2.4. Antituberculosis medicines
  • No observations
Tablet (scored)
Country lists
ATC N/A
Composition 150 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.2.4. Antituberculosis medicines
  • No observations
PAHO Strategic Fund Medicine List
2.3. Antituberculosis med.
  • Others observations:
    Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Tablet
Country lists
ATC N/A
Composition 500 mg
Observations for this pharmaceutical form can be found on the lists:
Colombia
02. Tuberculostatics
  • No observations
Peru
6.2.4 Anti-Tuberculosis
  • No observations
Ecuador
Essential Medicines List - Ecuador
  • No observations
Chile
Essential and Prioritized Medications
  • No observations
Cuba
6.2.10 Antituberculosos y antileprosos
  • No observations
Oral liquid
Country lists
ATC N/A
Composition 30 mg/ml
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.2.4. Antituberculosis medicines
  • This medicine is only for children.
PAHO Strategic Fund Medicine List
2.3. Antituberculosis med.
  • Others observations:
    Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.